Here's how DOI.ORG makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

DOI . ORG {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Doi.org Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. Hosting Providers
  14. CDN Services

We began analyzing https://link.springer.com/article/10.1007/s00403-015-1571-1, but it redirected us to https://link.springer.com/article/10.1007/s00403-015-1571-1. The analysis below is for the second page.

Title[redir]:
Peroxisome proliferator-activated receptors (PPARs) and PPAR agonists: the ‘future’ in dermatology therapeutics? | Archives of Dermatological Research
Description:
Peroxisome proliferator-activated receptors (PPARs) are nuclear hormone receptors and comprise three different isoforms namely PPARα, PPARγ, and PPARβ/δ with PPARβ/δ being the predominant subtype in human keratinocytes. After binding with specific ligands, PPARs regulate gene expression, cell growth and differentiation, apoptosis, inflammatory responses, and tumorogenesis. PPARs also modulate a wide variety of skin functions including keratinocyte proliferation, epidermal barrier formation, wound healing, melanocyte proliferation, and sebum production. Recent studies have shown the importance of PPARs in the pathogenesis of many dermatological disorders. Clinical trials have suggested possible role of PPAR agonists in the management of various dermatoses ranging from acne vulgaris, psoriasis, hirsutism, and lipodystrophy to cutaneous malignancies including melanoma. This article is intended to be a primer for dermatologists in their understanding of clinical relevance of PPARs and PPAR agonists in dermatology therapeutics.

Matching Content Categories {📚}

  • Education
  • Science
  • Business & Finance

Content Management System {📝}

What CMS is doi.org built with?

Custom-built

No common CMS systems were detected on Doi.org, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of doi.org audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {💸}

We're unsure how the site profits.

Not every website is profit-driven; some are created to spread information or serve as an online presence. Websites can be made for many reasons. This could be one of them. Doi.org has a revenue plan, but it's either invisible or we haven't found it.

Keywords {🔍}

pubmed, article, google, scholar, cas, peroxisome, proliferatoractivated, dermatol, receptor, ppar, receptors, skin, central, gamma, ppars, invest, human, rosiglitazone, differentiation, dermatology, agonists, cell, psoriasis, res, expression, treatment, activators, role, med, proliferator, activated, ligands, lipodystrophy, melanoma, arch, nuclear, acne, inflammation, clin, atopic, dermatitis, pioglitazone, effects, inhibit, patients, content, gene, keratinocyte, epidermal, therapy,

Topics {✒️}

peroxisome proliferator-activated receptor-alpha-beta dioic acid compared peroxisome proliferator-activated receptors peroxisome-proliferator activated receptors peroxisome proliferator-activated receptor peroxisome-proliferator-activated receptor month download article/chapter peroxisome proliferators-activated receptor nuclear hormone receptors open-label pilot study liver-x-receptor activators β/δ stimulates differentiation ppar{gamma} influences susceptibility antiretroviral-related adipocyte dysfunction phase ii study elevated waist/hip ratio bleomycin-induced skin fibrosis chauhan & ritu rawat dermatological research aims mouse fibroblasts results troglitazone improves psoriasis nuclear receptors role hair follicle development epithelium-mesenchyme interactions control long-term treatment experience acne vulgaris full article pdf ppar gamma ligands ciglitazone ppar β/δ abraham dj pioglitazone versus placebo placebo-controlled trial randomized controlled trial tetradecylthioacetic acid human melanoma cells pparγ ligand pioglitazone kömüves lg troglitazone therapy dendritic cell immunogenicity privacy choices/manage cookies ppar beta/delta rat embryonic development cultured human sebocytes human immortalized sebocytes vivo anti-melanoma effects fetal epidermal differentiation check access dmba-induced mammary instant access

Questions {❓}

  • Peroxisome proliferator-activated receptors (PPARs) and PPAR agonists: the ‘future’ in dermatology therapeutics?
  • Peroxisome proliferator-activated receptors (PPARs) and PPAR agonists: the ‘future’ in dermatology therapeutics?
  • Schuster M, Zouboulis CC, Ochsendorf F, Muller J, Thaci D, Bernd A et al (2011) Peroxisome proliferator-activated receptor activators protect sebocytes from apoptosis: a new treatment modality for acne?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Peroxisome proliferator-activated receptors (PPARs) and PPAR agonists: the ‘future’ in dermatology therapeutics?
         description:Peroxisome proliferator-activated receptors (PPARs) are nuclear hormone receptors and comprise three different isoforms namely PPARα, PPARγ, and PPARβ/δ with PPARβ/δ being the predominant subtype in human keratinocytes. After binding with specific ligands, PPARs regulate gene expression, cell growth and differentiation, apoptosis, inflammatory responses, and tumorogenesis. PPARs also modulate a wide variety of skin functions including keratinocyte proliferation, epidermal barrier formation, wound healing, melanocyte proliferation, and sebum production. Recent studies have shown the importance of PPARs in the pathogenesis of many dermatological disorders. Clinical trials have suggested possible role of PPAR agonists in the management of various dermatoses ranging from acne vulgaris, psoriasis, hirsutism, and lipodystrophy to cutaneous malignancies including melanoma. This article is intended to be a primer for dermatologists in their understanding of clinical relevance of PPARs and PPAR agonists in dermatology therapeutics.
         datePublished:2015-05-19T00:00:00Z
         dateModified:2015-05-19T00:00:00Z
         pageStart:767
         pageEnd:780
         sameAs:https://doi.org/10.1007/s00403-015-1571-1
         keywords:
            Acne vulgaris
            Ciglitazone
            Cutaneous malignancy
            Dioic acid
            PPARs
            PPAR agonists
            Peroxisome proliferator-activated receptors
            Pioglitazone
            Psoriasis
            Rosiglitazone
            Scleroderma
            Thiazolidinediones
            Troglitazone
            Zileuton
            Dermatology
         image:
         isPartOf:
            name:Archives of Dermatological Research
            issn:
               1432-069X
               0340-3696
            volumeNumber:307
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer Berlin Heidelberg
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Mrinal Gupta
               affiliation:
                     name:Dr. R. P. Govt. Medical College
                     address:
                        name:Department of Dermatology, Venereology and Leprosy, Dr. R. P. Govt. Medical College, Tanda, India
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Vikram K. Mahajan
               affiliation:
                     name:Dr. R. P. Govt. Medical College
                     address:
                        name:Department of Dermatology, Venereology and Leprosy, Dr. R. P. Govt. Medical College, Tanda, India
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Karaninder S. Mehta
               affiliation:
                     name:Dr. R. P. Govt. Medical College
                     address:
                        name:Department of Dermatology, Venereology and Leprosy, Dr. R. P. Govt. Medical College, Tanda, India
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Pushpinder S. Chauhan
               affiliation:
                     name:Dr. R. P. Govt. Medical College
                     address:
                        name:Department of Dermatology, Venereology and Leprosy, Dr. R. P. Govt. Medical College, Tanda, India
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ritu Rawat
               affiliation:
                     name:Dr. R. P. Govt. Medical College
                     address:
                        name:Department of Dermatology, Venereology and Leprosy, Dr. R. P. Govt. Medical College, Tanda, India
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Peroxisome proliferator-activated receptors (PPARs) and PPAR agonists: the ‘future’ in dermatology therapeutics?
      description:Peroxisome proliferator-activated receptors (PPARs) are nuclear hormone receptors and comprise three different isoforms namely PPARα, PPARγ, and PPARβ/δ with PPARβ/δ being the predominant subtype in human keratinocytes. After binding with specific ligands, PPARs regulate gene expression, cell growth and differentiation, apoptosis, inflammatory responses, and tumorogenesis. PPARs also modulate a wide variety of skin functions including keratinocyte proliferation, epidermal barrier formation, wound healing, melanocyte proliferation, and sebum production. Recent studies have shown the importance of PPARs in the pathogenesis of many dermatological disorders. Clinical trials have suggested possible role of PPAR agonists in the management of various dermatoses ranging from acne vulgaris, psoriasis, hirsutism, and lipodystrophy to cutaneous malignancies including melanoma. This article is intended to be a primer for dermatologists in their understanding of clinical relevance of PPARs and PPAR agonists in dermatology therapeutics.
      datePublished:2015-05-19T00:00:00Z
      dateModified:2015-05-19T00:00:00Z
      pageStart:767
      pageEnd:780
      sameAs:https://doi.org/10.1007/s00403-015-1571-1
      keywords:
         Acne vulgaris
         Ciglitazone
         Cutaneous malignancy
         Dioic acid
         PPARs
         PPAR agonists
         Peroxisome proliferator-activated receptors
         Pioglitazone
         Psoriasis
         Rosiglitazone
         Scleroderma
         Thiazolidinediones
         Troglitazone
         Zileuton
         Dermatology
      image:
      isPartOf:
         name:Archives of Dermatological Research
         issn:
            1432-069X
            0340-3696
         volumeNumber:307
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer Berlin Heidelberg
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Mrinal Gupta
            affiliation:
                  name:Dr. R. P. Govt. Medical College
                  address:
                     name:Department of Dermatology, Venereology and Leprosy, Dr. R. P. Govt. Medical College, Tanda, India
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Vikram K. Mahajan
            affiliation:
                  name:Dr. R. P. Govt. Medical College
                  address:
                     name:Department of Dermatology, Venereology and Leprosy, Dr. R. P. Govt. Medical College, Tanda, India
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Karaninder S. Mehta
            affiliation:
                  name:Dr. R. P. Govt. Medical College
                  address:
                     name:Department of Dermatology, Venereology and Leprosy, Dr. R. P. Govt. Medical College, Tanda, India
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Pushpinder S. Chauhan
            affiliation:
                  name:Dr. R. P. Govt. Medical College
                  address:
                     name:Department of Dermatology, Venereology and Leprosy, Dr. R. P. Govt. Medical College, Tanda, India
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ritu Rawat
            affiliation:
                  name:Dr. R. P. Govt. Medical College
                  address:
                     name:Department of Dermatology, Venereology and Leprosy, Dr. R. P. Govt. Medical College, Tanda, India
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Archives of Dermatological Research
      issn:
         1432-069X
         0340-3696
      volumeNumber:307
Organization:
      name:Springer Berlin Heidelberg
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Dr. R. P. Govt. Medical College
      address:
         name:Department of Dermatology, Venereology and Leprosy, Dr. R. P. Govt. Medical College, Tanda, India
         type:PostalAddress
      name:Dr. R. P. Govt. Medical College
      address:
         name:Department of Dermatology, Venereology and Leprosy, Dr. R. P. Govt. Medical College, Tanda, India
         type:PostalAddress
      name:Dr. R. P. Govt. Medical College
      address:
         name:Department of Dermatology, Venereology and Leprosy, Dr. R. P. Govt. Medical College, Tanda, India
         type:PostalAddress
      name:Dr. R. P. Govt. Medical College
      address:
         name:Department of Dermatology, Venereology and Leprosy, Dr. R. P. Govt. Medical College, Tanda, India
         type:PostalAddress
      name:Dr. R. P. Govt. Medical College
      address:
         name:Department of Dermatology, Venereology and Leprosy, Dr. R. P. Govt. Medical College, Tanda, India
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Mrinal Gupta
      affiliation:
            name:Dr. R. P. Govt. Medical College
            address:
               name:Department of Dermatology, Venereology and Leprosy, Dr. R. P. Govt. Medical College, Tanda, India
               type:PostalAddress
            type:Organization
      name:Vikram K. Mahajan
      affiliation:
            name:Dr. R. P. Govt. Medical College
            address:
               name:Department of Dermatology, Venereology and Leprosy, Dr. R. P. Govt. Medical College, Tanda, India
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Karaninder S. Mehta
      affiliation:
            name:Dr. R. P. Govt. Medical College
            address:
               name:Department of Dermatology, Venereology and Leprosy, Dr. R. P. Govt. Medical College, Tanda, India
               type:PostalAddress
            type:Organization
      name:Pushpinder S. Chauhan
      affiliation:
            name:Dr. R. P. Govt. Medical College
            address:
               name:Department of Dermatology, Venereology and Leprosy, Dr. R. P. Govt. Medical College, Tanda, India
               type:PostalAddress
            type:Organization
      name:Ritu Rawat
      affiliation:
            name:Dr. R. P. Govt. Medical College
            address:
               name:Department of Dermatology, Venereology and Leprosy, Dr. R. P. Govt. Medical College, Tanda, India
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Department of Dermatology, Venereology and Leprosy, Dr. R. P. Govt. Medical College, Tanda, India
      name:Department of Dermatology, Venereology and Leprosy, Dr. R. P. Govt. Medical College, Tanda, India
      name:Department of Dermatology, Venereology and Leprosy, Dr. R. P. Govt. Medical College, Tanda, India
      name:Department of Dermatology, Venereology and Leprosy, Dr. R. P. Govt. Medical College, Tanda, India
      name:Department of Dermatology, Venereology and Leprosy, Dr. R. P. Govt. Medical College, Tanda, India
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(421)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

Emails and Hosting {✉️}

Mail Servers:

  • mx.zoho.eu
  • mx2.zoho.eu
  • mx3.zoho.eu

Name Servers:

  • josh.ns.cloudflare.com
  • zita.ns.cloudflare.com

CDN Services {📦}

  • Crossref

4.88s.